Dr Ryan Arthur Mcconnell, MD - Medicare Gastroenterology in Palo Alto, CA

Dr Ryan Arthur Mcconnell, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Palo Alto, California. He went to Baylor College Of Medicine and graduated in 2009 and has 15 years of diverse experience with area of expertise as Gastroenterology. He is a member of the group practice Sutter Bay Medical Foundation and his current practice location is 795 El Camino Real, Palo Alto, California. You can reach out to his office (for appointments etc.) via phone at (650) 853-2972.

Dr Ryan Arthur Mcconnell is licensed to practice in California (license number A129683) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013151588.

Contact Information

Dr Ryan Arthur Mcconnell, MD
795 El Camino Real,
Palo Alto, CA 94301
(650) 853-2972
Not Available



Physician's Profile

Full NameDr Ryan Arthur Mcconnell
GenderMale
SpecialityGastroenterology
Experience15 Years
Location795 El Camino Real, Palo Alto, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Ryan Arthur Mcconnell attended and graduated from Baylor College Of Medicine in 2009
  NPI Data:
  • NPI Number: 1013151588
  • Provider Enumeration Date: 04/28/2009
  • Last Update Date: 06/02/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 8729241211
  • Enrollment ID: I20170612002988

Medical Identifiers

Medical identifiers for Dr Ryan Arthur Mcconnell such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013151588NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RG0100XInternal Medicine - Gastroenterology A129683 (California)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Sutter Bay Medical Foundation42845387782941

News Archive

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

Research finding could help predict the next outbreak of plague

Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.

Russian scientists propose new method to study tissue changes after laser surgery

Although currently laser surgery is a very popular tool for various vision disorders correction, it is still difficult to ensure proper control over the accuracy, efficiency and safety of such procedures.

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Ryan Arthur Mcconnell allows following entities to bill medicare on his behalf.
Entity NameStanford Health Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437292927
PECOS PAC ID: 6709797491
Enrollment ID: O20031124000348

News Archive

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

Research finding could help predict the next outbreak of plague

Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.

Russian scientists propose new method to study tissue changes after laser surgery

Although currently laser surgery is a very popular tool for various vision disorders correction, it is still difficult to ensure proper control over the accuracy, efficiency and safety of such procedures.

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Read more Medical News

› Verified 2 days ago

Entity NameSutter Bay Medical Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013950807
PECOS PAC ID: 4284538778
Enrollment ID: O20031125000909

News Archive

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

Research finding could help predict the next outbreak of plague

Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.

Russian scientists propose new method to study tissue changes after laser surgery

Although currently laser surgery is a very popular tool for various vision disorders correction, it is still difficult to ensure proper control over the accuracy, efficiency and safety of such procedures.

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Read more Medical News

› Verified 2 days ago

Entity NameSutter Bay Medical Foundation
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1982845186
PECOS PAC ID: 4284538778
Enrollment ID: O20090501000247

News Archive

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

Research finding could help predict the next outbreak of plague

Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.

Russian scientists propose new method to study tissue changes after laser surgery

Although currently laser surgery is a very popular tool for various vision disorders correction, it is still difficult to ensure proper control over the accuracy, efficiency and safety of such procedures.

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Read more Medical News

› Verified 2 days ago

Entity NameSutter Bay Medical Foundation
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1104067115
PECOS PAC ID: 4284538778
Enrollment ID: O20090501000456

News Archive

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

Research finding could help predict the next outbreak of plague

Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.

Russian scientists propose new method to study tissue changes after laser surgery

Although currently laser surgery is a very popular tool for various vision disorders correction, it is still difficult to ensure proper control over the accuracy, efficiency and safety of such procedures.

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Read more Medical News

› Verified 2 days ago

Entity NameSutter Bay Medical Foundation
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1497996524
PECOS PAC ID: 4284538778
Enrollment ID: O20090506000097

News Archive

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

Research finding could help predict the next outbreak of plague

Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.

Russian scientists propose new method to study tissue changes after laser surgery

Although currently laser surgery is a very popular tool for various vision disorders correction, it is still difficult to ensure proper control over the accuracy, efficiency and safety of such procedures.

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ryan Arthur Mcconnell is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ryan Arthur Mcconnell, MD
325 Distel Cir,
Los Altos, CA 94022-1408

Ph: (650) 853-2972
Dr Ryan Arthur Mcconnell, MD
795 El Camino Real,
Palo Alto, CA 94301

Ph: (650) 853-2972

News Archive

New study identifies possible treatment to block deposition of calcium in arterial wall

HGPS is a rare genetic disease that affects one in every 4-8 million births. The disease is caused by a spontaneous mutation in one of the two copies (alleles) of the gene LMNA, which codes for lamin A, a protein important for the integrity and function of the envelope surrounding the cell nucleus. The mutation causes incorrect processing of the messenger RNA for lamin proteins, resulting in the synthesis of an anomalous protein, called progerin.

Research finding could help predict the next outbreak of plague

Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.

Russian scientists propose new method to study tissue changes after laser surgery

Although currently laser surgery is a very popular tool for various vision disorders correction, it is still difficult to ensure proper control over the accuracy, efficiency and safety of such procedures.

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen, Inc. today announced that administration of investigational therapy FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), reversed the process of fibrosis in a preclinical model of radiation-induced lung fibrosis, a finding that has implications for treating multiple types of fibrotic disease.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Palo Alto, CA

Daniel Joseph Razzano, M.D.
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304
Phone: 650-493-5000    
Mahnoosh Kuhbanani Seifoddini, M.D.
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: 3801 Miranda Ave, Va Palo Alto Health Care System (111stc), Palo Alto, CA 94304
Phone: 209-946-3400    
Dr. Yusra Nazar Hussain, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 770 Welch Rd, Suite # 250, Palo Alto, CA 94304
Phone: 650-328-1676    Fax: 650-445-0911
Christopher Demuth Sharp, MD
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 900 Blake Wilbur Dr, Palo Alto, CA 94304
Phone: 650-723-6028    Fax: 650-725-7078
Dr. David Yao, M.D.
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: 3801 Miranda Ave, Medical Services (111a), Palo Alto, CA 94304
Phone: 650-493-5000    
Dr. Franklin Perry, M.D.
Gastroenterology
Medicare: Not Enrolled in Medicare
Practice Location: 2175 Park Blvd, Palo Alto, CA 94306
Phone: 650-330-3688    Fax: 650-330-3686

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.